Study finds no standard threshold for use of revascularization in some non-STEMI patients

03/4/2014 | Healio (free registration)

A study of 42,535 patients with non-STEMI and considerable three-vessel or left main coronary disease found no standard threshold for using revascularization treatment. Among the patients, 17.6% were medically managed "even in hospitals with full revascularization capacities" and even though patients with three-vessel disease are known to benefit from revascularization, the researchers wrote. "Since the use of MMS varies widely across hospitals despite a relatively similar hospital-level case mix, these findings suggest that there is no standard threshold for the use of revascularization in [non-]STEMI patients with [three-vessel disease]/[left main disease]," they wrote.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ